SINGULAIR - 0006-9275-31 - (montelukast sodium)

Alphabetical Index


Drug Information of SINGULAIR

Product NDC: 0006-9275
Proprietary Name: SINGULAIR
Non Proprietary Name: montelukast sodium
Active Ingredient(s): 5    mg/1 & nbsp;   montelukast sodium
Administration Route(s): ORAL
Dosage Form(s): TABLET, CHEWABLE
Coding System: National Drug Codes(NDC)

Labeler Information of SINGULAIR

Product NDC: 0006-9275
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020830
Marketing Category: NDA
Start Marketing Date: 19980220

Package Information of SINGULAIR

Package NDC: 0006-9275-31
Package Description: 30 TABLET, CHEWABLE in 1 BOTTLE (0006-9275-31)

NDC Information of SINGULAIR

NDC Code 0006-9275-31
Proprietary Name SINGULAIR
Package Description 30 TABLET, CHEWABLE in 1 BOTTLE (0006-9275-31)
Product NDC 0006-9275
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name montelukast sodium
Dosage Form Name TABLET, CHEWABLE
Route Name ORAL
Start Marketing Date 19980220
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name MONTELUKAST SODIUM
Strength Number 5
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of SINGULAIR


General Information